InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Summit Therapeutics Inc.

SMMT Clue Score37
United States Fiscal year ends December CIK 0001599298
$17.59 +2.45% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $17.59 +239.58% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 11 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue2.3Net income−21.4EPS, diluted−0.35Fiscal year 2018Fiscal year 2019Revenue57.1Operating income5.4Net income10.9EPS, diluted0.63Fiscal year 2019Revenue0.7 −98.7%Operating income−27.5Net income−29.1 −368.0%EPS, diluted−0.89Fiscal year 2020Revenue0.9 +15.7%Operating income−53.2Net income−52.7EPS, diluted−0.76Fiscal year 2021Revenue1.8 +110.3%Operating income−86.2Net income−88.6EPS, diluted−0.67Fiscal year 2022Revenue0.7 −61.0%Operating income−72.1Net income−78.8EPS, diluted−0.41Fiscal year 2023Revenue0.0 −100.0%Operating income−609.7Net income−614.9EPS, diluted−0.99Fiscal year 2024Revenue0.0Operating income−226.0Net income−221.3EPS, diluted−0.31Fiscal year 2025Net income−1,079.6EPS, diluted−1.44
FY2017FY2018FY2019FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 2.3 n/a 57.1 0.7 0.9 1.8 0.7 0.0 0.0 n/a
Growth −98.7% +15.7% +110.3% −61.0% −100.0%
Operating income n/a n/a 5.4 −27.5 −53.2 −86.2 −72.1 −609.7 −226.0 n/a
Net income −21.4 n/a 10.9 −29.1 −52.7 −88.6 −78.8 −614.9 −221.3 −1,079.6
Growth −368.0%
EPS, diluted −0.35 n/a 0.63 −0.89 −0.76 −0.67 −0.41 −0.99 −0.31 −1.44

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2017Gross margin−1,078.7%Net margin−927.6%Free cash flow margin523.4%Fiscal year 2018Fiscal year 2019Gross margin4.7%Operating margin9.4%Net margin19.0%Free cash flow margin−61.8%Fiscal year 2019Gross margin−3,409.4%Operating margin−3,697.6%Net margin−3,920.2%Free cash flow margin−2,821.3%Fiscal year 2020Operating margin−6,185.2%Net margin−6,127.6%Free cash flow margin−5,643.3%Fiscal year 2021Operating margin−4,764.3%Net margin−4,897.8%Free cash flow margin−4,029.5%Fiscal year 2022Operating margin−10,225.4%Net margin−11,174.8%Free cash flow margin−5,986.7%Fiscal year 2023Fiscal year 2024Fiscal year 2025
FY2017FY2018FY2019FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin −1,078.7% n/a 4.7% −3,409.4% n/a n/a n/a n/a n/a n/a
Operating margin n/a n/a 9.4% −3,697.6% −6,185.2% −4,764.3% −10,225.4% n/a n/a n/a
Net margin −927.6% n/a 19.0% −3,920.2% −6,127.6% −4,897.8% −11,174.8% n/a n/a n/a
Free cash flow margin 523.4% n/a −61.8% −2,821.3% −5,643.3% −4,029.5% −5,986.7% n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow12.1Capital expenditure−0.1Free cash flow12.1Fiscal year 2018Fiscal year 2019Operating cash flow−35.1Capital expenditure−0.2Free cash flow−35.3Dividends paid0.0Fiscal year 2019Operating cash flow−20.8Capital expenditure−0.2Free cash flow−21.0Dividends paid0.0Fiscal year 2020Operating cash flow−48.1Capital expenditure−0.4Free cash flow−48.5Dividends paid0.0Fiscal year 2021Operating cash flow−72.6Capital expenditure−0.3Free cash flow−72.9Fiscal year 2022Operating cash flow−41.6Capital expenditure−0.6Free cash flow−42.2Fiscal year 2023Operating cash flow−76.8Capital expenditure−0.1Free cash flow−76.9Fiscal year 2024Operating cash flow−142.1Capital expenditure−0.1Free cash flow−142.2Fiscal year 2025Operating cash flow−322.9Capital expenditure−0.7Free cash flow−323.6
FY2017FY2018FY2019FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 12.1 n/a −35.1 −20.8 −48.1 −72.6 −41.6 −76.8 −142.1 −322.9
Capital expenditure −0.1 n/a −0.2 −0.2 −0.4 −0.3 −0.6 −0.1 −0.1 −0.7
Free cash flow 12.1 n/a −35.3 −21.0 −48.5 −72.9 −42.2 −76.9 −142.2 −323.6
Growth
Dividends paid n/a n/a 0.0 0.0 0.0 n/a n/a n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2017Cash35.3Shareholders’ equity−4.4Fiscal year 2018Cash28.5Shareholders’ equity−3.6Fiscal year 2019Cash35.2Shareholders’ equity57.6Fiscal year 2019Cash63.8Shareholders’ equity78.9Fiscal year 2020Cash66.4Shareholders’ equity79.5Fiscal year 2021Cash71.8Shareholders’ equity83.3Fiscal year 2022Cash348.6Shareholders’ equity126.7Fiscal year 2023Cash71.4Shareholders’ equity77.7Fiscal year 2024Cash104.9Shareholders’ equity388.7Fiscal year 2025Cash225.3Shareholders’ equity658.9
FY2017FY2018FY2019FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 35.3 28.5 35.2 63.8 66.4 71.8 348.6 71.4 104.9 225.3
Shareholders’ equity −4.4 −3.6 57.6 78.9 79.5 83.3 126.7 77.7 388.7 658.9

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Jan 2017 FY2018 31 Jan 2018 FY2019† 31 Jan 2019 FY2019† 31 Dec 2019 FY2020† 31 Dec 2020 FY2021† 31 Dec 2021 FY2022 31 Dec 2022 FY2023† 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
2.3 n/a 57.1 0.7 0.9 1.8 0.7 0.0 0.0 n/a
Growth −98.7% +15.7% +110.3% −61.0% −100.0%
−24.9 −25.8 2.7 −25.3 n/a n/a n/a n/a n/a n/a
Growth −1,047.7%
19.0 29.0 39.2 31.2 n/a n/a n/a n/a n/a n/a
8.3 11.9 12.3 9.9 19.2 23.6 26.7 29.3 60.2 556.8
n/a n/a 5.4 −27.5 −53.2 −86.2 −72.1 −609.7 −226.0 n/a
Growth −609.8%
−25.7 n/a 9.1 −29.1 −52.9 −88.6 −78.8 −614.9 −221.3 −1,079.6
−4.3 n/a −1.8 0.0 −0.2 0.0 n/a 0.0 0.0 0.0
−21.4 n/a 10.9 −29.1 −52.7 −88.6 −78.8 −614.9 −221.3 −1,079.6
Growth −368.0%
Per share
−0.35 n/a 0.63 −0.89 −0.76 −0.67 −0.41 −0.99 −0.31 −1.44
−0.35 n/a 0.63 −0.89 −0.76 −0.67 −0.41 −0.99 −0.31 −1.44
Growth −241.3%
61.5 n/a 17.1 32.8 69.5 131.7 193.3 619.6 718.5 747.7
61.5 n/a 17.2 32.8 69.5 131.7 193.3 619.6 718.5 747.7
Growth +90.5% +111.8% +89.5% +46.8% +220.5% +16.0% +4.1%

† The diluted share count jumps at 2019 and 2019 and 2020 and 2021 and 2023, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 8 of 9 years on file.